The outlook of companies tied to the drug's legacy presents a challenging investment landscape. While the initial success generated substantial gains, generic alternatives have significantly eroded sales . https://porn454252.tinyblogging.com/copyright-s-flagship-product-and-big-pharma-a-risky-opportunity-85970708